Advertisement

Diagnosis of Portal Vein Thrombosis

  • Shigehiro Kokubu
Chapter

Abstract

Portal vein thrombosis is considered to develop from portal venous vascular wall disorder, abnormal portal venous flow, and abnormalities of the blood coagulation system as the thrombogenic origins. Portal vein thrombosis can easily occur in patients with hepatic cirrhosis due to three additional factors. The first factor is the hyperpermeability of the gastrointestinal mucous membrane. Cirrhosis creates an environment susceptible to bacterial translocation, and loads to the flow of lipopolysaccharide into a portal vein, resulting in sinusoid wall injury. The second factor is clot formation promoted by portal venous congestion (sluggish blood flow) due to portal hypertension. The third factor is a decrease of antithrombin-III synthesis in liver cirrhosis. Among the underlying diseases of 539 cases of portal vein thrombosis in Japan in 2014, there were 434 cases (80.5%) of portal hypertension, whose breakdown consisted of 406 cases (75.3%) of liver cirrhosis, 25 cases of idiopathic portal hypertension, 8 cases of extrahepatic obstruction, and 7 cases of others, while 105 cases (19.5%) were not associated with portal hypertension. Secondary portal vein thrombus accounted for 69 (12.8%) of the total, if it is defined as that developed within 30 days after an operation or interventional radiology.

Keywords

Etiology of portal thrombus Liver cirrhosis Protein C Protein S Secondary portal thrombus 

References

  1. 1.
    DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology. 2009;49:1729–64.CrossRefGoogle Scholar
  2. 2.
    Okuda K, Ohnishi K, Kimura K, Matsutani S, Sumida M, Goto N, et al. Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology. 1985;89:279–86.CrossRefGoogle Scholar
  3. 3.
    Francoz C, Belghiti J, Vilgrain V, Sommacale D, Paradis V, Condat B, et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut. 2005;54:691–7.CrossRefGoogle Scholar
  4. 4.
    Amitrano L, Guardascione MA, Brancaccio V, Margaglione M, Manguso F, Iannaccone L, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol. 2004;40:736–41.CrossRefGoogle Scholar
  5. 5.
    Kojima S, Watanabe N, Matsutani S, Oho K, Ohta M, Koizumi J, Kokubu S, et al. Current status of portal vein thrombosis in Japan: the results of the questionnaire survey. J JSPH. 2016;22(2):176–89.Google Scholar
  6. 6.
    Okuwaki Y, Kokubu S. In: Japan Society of Portal Hypertension, editors. Portal vein thrombosis: clinical manual of portal hypertension. Tokyo: Nankodo; 2015.Google Scholar
  7. 7.
    Tessler FN, Gehring BJ, Gomes AS, Perrella RR, Ragavendra N, Busuttil RW, et al. Diagnosis of portal vein thrombosis: value of color Doppler imaging. AJR Am J Roentgenol. 1991;157:293–6.CrossRefGoogle Scholar
  8. 8.
    Rossi S, Rosa L, Ravetta V. Contrast-enhanced versus conventional and color Doppler sonography for the detection of thrombosis of the portal and hepatic venous system. AJR Am J Roentgenol. 2006;186:763–73.CrossRefGoogle Scholar
  9. 9.
    Maruyama H, Takahashi M, Shimada T, Yokosuka O. Emergency anticoagulation treatment for cirrhosis patients with portal vein thrombosis and acute variceal bleeding. Scand J Gastroenterol. 2012;47(6):686–91.CrossRefGoogle Scholar
  10. 10.
    Parvey HR, Raval B, Sandler CM. Portal vein thrombosis: imaging findings. AJR Am J Roentgenol. 1994;162:77–81.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Shigehiro Kokubu
    • 1
  1. 1.Shin-yurigaoka General Hospital Institute for Liver Disease Minimal Invasive Treatment center, Endoscopic CenterKawasakiJapan

Personalised recommendations